Industry Insights
-
Tips For Successfully Scaling Your cGMP Manufacturing
6/23/2022
What are the specific obstacles to expanding manufacturing capacity? Cell therapy industry leaders share what to look for in a solutions provider and recommendations for navigating your road ahead.
-
Bioprocessing: ISO/TS 23565 – Highlights And Interpretation
12/12/2022
ISO/TS 23565 addresses an unmet need in cell processing systems. Explore the general requirements and considerations for equipment systems used in the manufacturing of cells for therapeutic use.
-
When The Goal Is To Be (Bio)similar, What Does Differentiation Mean?
10/13/2017
As concerns about the cost of medicines reach a fever pitch, innovators are looking to leverage a promising advancement to help address the fundamental need for sustainable healthcare in the U.S. — biosimilars.
-
The Coevolution Of The Single-Use And Biopharmaceutical Industries
11/17/2022
Learn more about the evolution of one company's solutions for biopharmaceutical manufacturing and accelerating market entrance using single-use technology.
-
6 Ways AI Is Transforming The Life Sciences (Already)
1/31/2019
Most in the life sciences agree that artificial intelligence (AI) will reshape the sector from R&D through commercial. Although AI has only just left the starting gate, and most activity is in exploratory phases, some benefits are starting to emerge. And there are pockets of early adopters trailblazing new approaches and seeking a competitive edge.
-
The Ongoing Pursuit Of Manufacturing Digitalization
11/1/2022
Explore Pharm 4.0, how this methodology can help with the growing demand for Oligo drug substance, and the benefits made possible by its digitalization plan.
-
The Importance Of Finding The Right Media For Your CHO Subtype
9/28/2022
Learn about the origin of CHO cell lines and how testing different media can help optimize your upstream production process.
-
New Manufacturing Strategies For The Precision Medicine Future
10/25/2019
The increased cost of targeted active pharmaceutical ingredients (APIs) creates new challenges. Learn how precision medicine will change pharmaceutical manufacturing, and how you can prepare.
-
Why You Should Engage With Regulatory Early In Product Development
2/7/2018
Involving regulatory affairs early in the development process facilitates execution of the development pathway while considering both regulatory requirements and the company’s business needs.
-
The Changing Face Of Non-Clinical Development
9/2/2015
The complexity of non-clinical safety studies has been increasing in recent years as researchers seek to obtain as much information as possible about the safety and pharmacology of their therapeutics prior to commencing clinical studies.